ArticleMolecular cancer2018

Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer.

Soon-Ki Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.